NAMD Submits Comments on Medicaid Drug Rebate Program Proposed Rule
On July 25, NAMD submitted comments on CMS's proposed rule on the Medicaid Drug Rebate Program (MDRP).
Benefits
Prescription Drugs
Every state has chosen to cover prescription drugs in their Medicaid programs. Medicaid agencies are pursuing innovative strategies to manage the rising cost of prescription drugs.
Resources
Prescription Drug Spending: What’s Coming Next for Medicaid and How Can States Prepare?
Experts at the NAMD Fall Conference discussed challenges with high-cost drugs.
NAMD Comments on Medicare’s Proposed Coverage Determination for Alzheimer’s Drug
On February 9, 2022, NAMD submitted comments on Medicare’s proposed National Coverage Determination (NCD) of Coverage with Evidence...
NAMD Submits Letter of Support for MACPAC’s Accelerated Approval Pathway Drug Rebate Proposal
On April 7, NAMD sent a letter to the Medicaid and CHIP Payment and Access Commission (MACPAC) supporting...
NAMD Provides Thoughts on High-Cost Drugs to Senate Finance
In March 2016, NAMD responded to a Senate Finance Committee Request for Information on prescription drug costs and...